Study Information

Study Title

Assessing Thymidine Kinase (TK) levels in HR+ Metastatic Breast Cancer

Study Summary

The purpose of this clinical trial is to evaluate the difference in thymidine kinase levels in patients who are being treated for hormone receptor positive (+) metastatic breast cancer, throughout their regimen.

Disease State

Hormone Receptor Positive (+) Metastatic Breast Cancer

Principal Investigator

Myron Bednar, MD

Phase Observational

If you have any questions regarding this study or think that you or your loved one may be eligible, please contact our Clinical Trial Coordinator by dialing 908.237.1201 extension 262.